🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT05747703
Active, not recruiting Not applicable

Telehealth Treatment for Alcohol Use Disorder

NCT05747703 · tracked via the Priya Life Science USA tracker
Sponsor
Ria Health
Phase
Not applicable
Started
2024-01-31
Last updated
2026-06-30

Condition(s) studied

Alcohol Use DisorderAlcohol DependenceAlcoholism

Investigational drug(s) / intervention(s)

Ria Treatment Platform

Ria Treatment Platform: combined medication, coaching, education, and monitoring

Study summary

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * alcohol use disorder Exclusion Criteria: * inability to provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Stanford University Stanford California
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05747703 on ClinicalTrials.gov ↗ ← All trials in the USA